KBL Merger Corp. IV (KBLM), filed a definitive proxy this evening for their upcoming extension vote on April 8th, to extend their deadline from April 9, 2020 to July 9, 2020. However, KBLM is offering a very, very attractive $55,000 per month contribution to trust for non-redeeming shareholders, which equates to, at a minimum (assuming no one redeems) $0.049 per share per month, up to a maximum of $0.099 per month…for three months.
So let’s assume the maximum amount of shareholders redeem and everyone who didn’t redeem is entitled to $0.099 per month. That means those shareholders are entitled to receive $0.297 total if all three months are needed for KBLM to complete their combination with CannBioRx. Which, in the current climate, an additional three months is not that out of the realm of possibility. There are only 1,114,267 SPAC shares left currently outstanding, but with a very juicy contribution to trust, this should definitely make any potential redeemers pause and reconsider.
One important note: in order to redeem you MUST be a shareholder of record, of which, the record date is March 12, 2020. So, if you bought KBLM’s shares and they settled after March 12th, you cannot vote and therefore, cannot be eligible to redeem.
Bottom line, preservation of cash is important and the Coronavirus is cashing in chits…going to make teams pay one way or another.
Remember the metaverse? Many do not. Meta’s (NASDAQ:META) attempted transition to virtually living and working seemed to mark a trend that went up and down quickly, but one SPAC deal has both survived that roller coaster and may rise with a second. Back in December 2022, Newbury Street (NASDAQ:NBST) announced a $1.85 billion combination with...
At the SPAC of Dawn Tucked into the bill that provides $95 billion in funding to American allies passed by the House this weekend is another measure that is likely to have far more impact on at least one pending deal in SPAC world. It would appear that the timing was fortuitous for TikTok rival...
With the passage this weekend of $95 billion in funding for Ukraine, Israel and Taiwan by the House of Representatives, some focus has gone back towards the defense sector, which has generally had a good year as a whole. But, SPACs have not been as active in defense, despite the fact that companies in the...
At the SPAC of Dawn As April’s sleepy month for SPAC news continues, there is only one special meeting on the docket to consider a SPAC deal approval, that being today’s vote on Pegasus Digital Mobility‘s (NYSE:PGSS) combination with equipment manufacturer Schmid. Three more SPACs are facing extension votes this week, including Pyrophyte (NYSE:PHYT), whose...
Terms Tracker for the Week Ending April 19, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Passover and school spring break starts next week, which most likely means a slowdown in SPAC filing activity. Although Churchill IX is now rumored to...